What is the current price of BRN.AX stock?

BRN.AX stock is trading at A$0.185 intraday on 17 Jan 2026, with a day high of A$0.190, day low of A$0.185 and volume of 2,379,569 shares as reported on the ASX.

What valuation metrics matter for BRN.AX stock?

Key metrics include price/sales **203.79**, price/book **15.51**, EPS **-0.02** and trailing PE **-8.50**. These show high valuation relative to revenue and current negative earnings, raising execution risk.

What is Meyka AI's forecast for BRN.AX stock?

Meyka AI's forecast model projects a 12‑month price of A$0.231 for BRN.AX stock, implying about 24.86% upside from A$0.185. Forecasts are model-based projections and not guarantees.

What are the main risks for BRN.AX stock investors?

Primary risks include continued negative margins, high valuation multiples, execution risk on Akida adoption, and low free cash flow per share. These factors make BRN.AX stock higher risk within AI stocks.

AU Stocks

BRN.AX BrainChip (ASX): A$0.185 intraday, 2.38m volume signals AI interest

ByHuzaifa Zahoor January 17, 2026

BRN.AX stock is trading at A$0.185 intraday on the ASX on 17 Jan 2026, up 2.78% with 2,379,569 shares changing hands. The move sits between the 50-day average A$0.176 and the 200-day average A$0.204, showing short-term buyer interest while the medium trend remains mixed. We examine why the Akida neuromorphic chip roadmap, cash metrics and technical signs matter for traders and longer-term investors in the AI stocks sector.